HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,910,718 | +50.4% | 144,125 | +42.9% | 0.00% | 0.0% |
| Q2 2023 | $8,585,602 | -32.8% | 100,841 | -34.7% | 0.00% | 0.0% |
| Q1 2023 | $12,779,497 | +32.9% | 154,435 | +26.4% | 0.00% | 0.0% |
| Q4 2022 | $9,612,918 | +43.4% | 122,224 | +35.0% | 0.00% | 0.0% |
| Q3 2022 | $6,702,000 | -10.8% | 90,527 | -21.5% | 0.00% | 0.0% |
| Q2 2022 | $7,512,000 | -45.4% | 115,256 | -47.0% | 0.00% | 0.0% |
| Q1 2022 | $13,751,000 | +10.8% | 217,494 | -7.1% | 0.00% | 0.0% |
| Q4 2021 | $12,414,000 | -25.0% | 234,074 | -0.2% | 0.00% | -50.0% |
| Q3 2021 | $16,555,000 | -8.4% | 234,531 | -13.6% | 0.00% | 0.0% |
| Q2 2021 | $18,082,000 | -35.0% | 271,338 | +8.3% | 0.00% | -33.3% |
| Q1 2021 | $27,806,000 | +37.8% | 250,469 | +47.4% | 0.00% | 0.0% |
| Q4 2020 | $20,181,000 | +48.1% | 169,949 | +8.8% | 0.00% | +50.0% |
| Q3 2020 | $13,628,000 | +34.2% | 156,190 | +37.7% | 0.00% | 0.0% |
| Q2 2020 | $10,158,000 | +33.4% | 113,411 | +48.4% | 0.00% | +100.0% |
| Q1 2020 | $7,615,000 | -31.7% | 76,411 | -21.3% | 0.00% | -50.0% |
| Q4 2019 | $11,152,000 | -4.6% | 97,061 | +4.7% | 0.00% | 0.0% |
| Q3 2019 | $11,693,000 | +0.3% | 92,702 | -4.4% | 0.00% | 0.0% |
| Q2 2019 | $11,663,000 | +31.0% | 96,924 | -4.8% | 0.00% | +100.0% |
| Q1 2019 | $8,905,000 | -14.4% | 101,791 | -2.2% | 0.00% | -50.0% |
| Q4 2018 | $10,409,000 | -18.3% | 104,034 | -6.5% | 0.00% | 0.0% |
| Q3 2018 | $12,743,000 | -36.3% | 111,216 | -50.1% | 0.00% | -33.3% |
| Q2 2018 | $19,999,000 | -27.6% | 222,994 | -40.9% | 0.00% | -40.0% |
| Q1 2018 | $27,613,000 | -10.8% | 377,412 | -29.2% | 0.01% | 0.0% |
| Q4 2017 | $30,949,000 | -19.5% | 532,849 | -37.8% | 0.01% | -16.7% |
| Q3 2017 | $38,439,000 | +48.4% | 856,667 | +30.6% | 0.01% | +20.0% |
| Q2 2017 | $25,899,000 | +25.2% | 655,840 | +28.6% | 0.01% | +25.0% |
| Q1 2017 | $20,690,000 | +18.5% | 509,990 | +17.5% | 0.00% | 0.0% |
| Q4 2016 | $17,454,000 | +18.6% | 434,170 | +6.9% | 0.00% | +33.3% |
| Q3 2016 | $14,712,000 | +27.1% | 406,298 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $11,577,000 | -40.9% | 399,354 | -28.7% | 0.00% | -40.0% |
| Q1 2016 | $19,593,000 | +23.5% | 560,098 | +13.8% | 0.01% | +25.0% |
| Q4 2015 | $15,861,000 | +4.0% | 491,986 | +4.3% | 0.00% | 0.0% |
| Q3 2015 | $15,247,000 | +258.1% | 471,730 | +358.1% | 0.00% | +300.0% |
| Q2 2015 | $4,258,000 | +87.1% | 102,967 | +103.3% | 0.00% | 0.0% |
| Q1 2015 | $2,276,000 | -15.5% | 50,653 | -29.6% | 0.00% | 0.0% |
| Q4 2014 | $2,692,000 | +50.6% | 71,949 | +40.6% | 0.00% | 0.0% |
| Q3 2014 | $1,787,000 | +23.0% | 51,164 | +24.2% | 0.00% | – |
| Q2 2014 | $1,453,000 | -51.9% | 41,185 | -55.5% | 0.00% | -100.0% |
| Q1 2014 | $3,018,000 | -22.9% | 92,610 | -0.4% | 0.00% | 0.0% |
| Q4 2013 | $3,916,000 | +17.6% | 92,967 | +11.3% | 0.00% | 0.0% |
| Q3 2013 | $3,330,000 | +1.2% | 83,498 | +4.9% | 0.00% | 0.0% |
| Q2 2013 | $3,292,000 | – | 79,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |